Clinical Trial Update: Safety and Efficacy of Ataluren (PTC124) for Cystic Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ataluren (PTC124) for cystic fibrosis evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• ataluren (ataluren)

Snippet

Sponsor: PTC Therapeutics | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED